HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.

12th Edition of International Conference on Neurology and Brain Disorders

October 20-22, 2025

October 20 -22, 2025 | Orlando, Florida, USA

Neuropharmacology and Novel Drug Development

Neuropharmacology and Novel Drug Development

The field of neuropharmacology and novel drug development delves into the biochemical pathways and molecular targets underlying neurological function and dysfunction. This research area is pivotal in driving the creation of innovative drugs, ranging from neuroprotective agents to neuromodulators. Advanced methodologies, such as CRISPR-based genome editing and nanotechnology, are transforming the delivery and effectiveness of neurotherapeutics. Researchers are also focusing on strategies to overcome the challenges of the blood-brain barrier, ensuring enhanced drug delivery to the central nervous system. With a strong focus on addressing unmet clinical needs, neuropharmacology is expanding the frontiers of science, paving the way for groundbreaking solutions to neurological and psychiatric disorders.

Related Sessions
Scientific Program
Keynote Presentation (In-Person)
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
View Profile HTML
Keynote Presentation (In-Person)
Title : TBI updates in 2025
Jonathan Eskenazi, Cedars Sinai / UCLA, United States
View Profile HTML
Keynote Presentation (In-Person)
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
View Profile HTML
Oral Presentation (In-Person)
Title : Non-pharmacological strategies to counteract oxaliplatin toxicity: Protective effects of vagal nerve stimulation and resistance training on neuropathy, motor dysfunction, and muscle atrophy
Ricardo Aparecido Baptista Nucci, Hospital Sirio-Libanes, Brazil
View Profile HTML
Oral Presentation (Virtual)
Title : Synapticare: Integrating sleep data and tau biomarkers to assess depression severity
Medha Menon, John Foster Dulles HS, United States
View Profile HTML
Keynote Presentation (Virtual)
Title : How have we eliminated infection: From the bone to brain?
Thomas J Webster, Interstellar Therapeutics, United States
View Profile HTML
View Full Scientific Program
Committee Members
Speaker at Neuroscience Conference - Ken Ware

Ken Ware

NeuroPhysics Therapy Institute and Research Centre, Australia
Speaker at Neurology and Brain Disorders - Joe Sam Robinson

Joe Sam Robinson

Mercer University, United States
Speaker at Neurology Conferences - Robert B Slocum

Robert B Slocum

University of Kentucky HealthCare, United States
View All Members
INBC 2025 Speakers
Speaker at Brain Disorders Conference - Thomas J Webster

Thomas J Webster

Interstellar Therapeutics, United States
Speaker at Neuroscience Conference - Roger H Coletti

Roger H Coletti

Interventional Health, PA, United States
Speaker at Neuroscience Conference - Stephen Grossberg

Stephen Grossberg

Boston University, United States
Speaker at Brain Disorders Conference - George Diaz

George Diaz

Memorial Healthcare Systems, United States
View All Speakers
Tags

Submit your abstract Today

Click Here
Watsapp